ANALYSIS | A key CUSMA ‘checkpoint’ is coming. Businesses and unions are balancing anxiety and hopeJune 30, 2026
How a law student became a Blues assistant GM: ‘He could do this for a Fortune 500 company’June 29, 2026
Share Twitter Facebook LinkedIn Email In lower- and middle-income countries, accessibility, cost, and talent are obstacles to broadly implementing cellular therapeutics into cancer care.Read More
ANALYSIS | A key CUSMA ‘checkpoint’ is coming. Businesses and unions are balancing anxiety and hopeJune 30, 2026